Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3)
This study is approved by the NHS Research and Ethics Committee (reference 22/NW/0051). Findings will be published in peer-reviewed journals and reports will be made available to participants.
Source: BMJ Open - Category: General Medicine Authors: Hazenberg, P., Robinson, R. E., Farrar, M., Solorzano, C., Hyder-Wright, A., Liatsikos, K., Brunning, J., Fleet, H., Bettam, A., Howard, A., Kenny-Nyazika, T., Urban, B., Mitsi, E., El Safadi, D., Davies, K., Lesosky, M., Gordon, S. B., Ferreira, D. M., C Tags: Open access, Respiratory medicine Source Type: research
More News: Epidemiology | General Medicine | Medical Ethics | Meningitis Vaccine | Pneomococcal Vaccine | Respiratory Medicine | Study | Vaccines